ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma

- Jackson, Evangeline R., Duchatel, Ryan J., Le Grand, Marion, Kearney, Padraic S., Douglas, Alicia M., Findlay, Izac J., Germon, Zacary P., McEwen, Holly P., Beitaki, Tyrone S., Patabendige, Adjanie, Skerrett-Byrne, David A., Nixon, Brett, Staudt, Dilana E., Smith, Nathan D., Day, B, Manoharan, N, Nagabushan, S, Hansford, JR, Govender, D, McCowage, GB, Firestein, R, Howlett, M, Endersby, R, Persson, Mika L., Gottardo, NG, Alvaro, F, Waszak, SM, Larsen, MR, Colino-Sanguino, Y, Valdés-Mora, F, Rakotomalala, A, Meignan, S, Pasquier, E, Andre, N, Mannan, Abdul, Hulleman, E, Eisenstat, DD, Vitanza, NA, Nazarian, J, Koschmann, C, Mueller, S, Cain, JE, Dun, MD, Yadavilli, Sridevi, Parackal, Sarah, Game, Shaye, Chong, Wai Chin, Jayasekara, W. Samantha N.

Pan-Cancer Analysis of Canonical and Modified miRNAs Enhances the Resolution of the Functional miRNAome in Cancer

- Distefano, Rosario, Tomasello, Luisa, Ma, Qin, Nigita, Giovanni, Croce, Carlo M., Rampioni Vinciguerra, Gian Luca, Gasparini, Pierluigi, Xiang, Yujia, Bagnoli, Marina, Marceca, Gioacchino P., Fadda, Paolo, Laganà, Alessandro, Acunzo, Mario

The emerging roles of rna m6a methylation and demethylation as critical regulators of tumorigenesis, drug sensitivity, and resistance

- Lan, Qing, Liu, Pei Y., Bell, Jessica L., Wang, Jenny Y., Hüttelmaier , Stefan, Zhang, Xu Dong, Zhang, Lirong, Liu, Tao

A p53-responsive miRNA network promotes cancer cell quiescence

- La, Ting, Liu, Guang Zhi, Guo, Su Tang, Liu, Tao, Thorne, Rick F., Jin, Lei, Zhang, Xu Dong, Farrelly, Margaret, Cole, Nicole, Feng, Yu Chen, Zhang, Yuan Yuan, Sherwin, Simonne K., Yari, Hamed, Tabatabaee, Hessam, Yan, Xu Guang

Skp2-mediated stabilization of MTH1 promotes survival of melanoma cells upon oxidative stress

- Wang, Jia Yu, Liu, Guang Zhi, Jin, Lei, Wilmott, James S., La, Ting, Feng, Yu Chen, Yari, Hamed, Yan, Xu Guang, Thorne, Rick F., Scolyer, Richard A., Zhang, Xu Dong

The histone methyltransferase DOT1L promotes neuroblastoma by regulating gene transcription

- Wong, Matthew, Tee, Andrew E. L., Liu, Pei Yan, Zhang, Xu Dong, Hüttelmaier, Stefan, Wong, Jason W. H., Wang, Jenny, Polly, Patsie, Perini, Giovanni, Scarlett, Christopher J., Liu, Tao, Milazzo, Giorgio, Bell, Jessica L., Poulos, Rebecca C., Atmadibrata, Bernard, Sun, Yuting, Jing, Duohui, Ho, Nicholas, Ling, Dora

Stomach-specific activation of oncogenic KRAS and STAT3-dependent inflammation cooperatively promote gastric tumorigenesis in a preclinical model

- Thiem, Stefan, Eissmann, Moritz F., Waring, Paul, Buchert, Michael, Jarnicki, Andrew, Ernst, Matthias, Elzer, Joachim, Jonas, Anna, Putoczki, Tracy L., Poh, Ashleigh, Nguyen, Paul, Preaudet, Adele, Flanagan, Dustin, Vincan, Elizabeth

Nerve-cancer cell cross-talk: a novel promoter of tumor progression

- Jobling, Phillip, Pundavela, Jay, Oliveira, Sonia M. R., Roselli, Séverine, Walker, Marjorie M., Hondermarck, Hubert

A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells

- Stehn, Justine R., Haass, Nikolas K., Allanson, Munif, Fath, Thomas, Hill, Timothy A., McCluskey, Adam, Schevzov, Galina, Palmer, Stephen J., Hardeman, Edna C., Winlaw, David, Reeve, Vivienne E., Dixon, Ian, Bonello, Teresa, Weninger, Wolfgang, Cripe, Timothy P., Gunning, Peter W., Desouza, Melissa, Kottyan, Gregg, Treutlein, Herbert, Zeng, Jun, Nascimento, Paula R. B. B., Sequeira, Vanessa B., Butler, Tanya L.

Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT⁺ cancers

- Roberts, Kathryn G., Smith, Amanda M., Sim, Alistair T. R., Ashman, Leonie K., Verrills, Nicole M., McDougall, Fiona, Carpenter, Helen, Horan, Martin, Neviani, Paolo, Powell, Jason A., Thomas, Daniel, Guthridge, Mark A., Perrotti, Danilo

Nucleotide excision repair gene expression after cisplatin treatment in melanoma

- Bowden, Nikola A., Ashton, Katie A., Kiejda, Kelly A., Zhang, Xu Dong, Hersey, Peter, Scott, Rodney J.

Inhibition of endoplasmic reticulum stress-induced apoptosis of melanoma cells by the ARC protein

- Chen, Li Hua, Jiang, Chen Chen, Watts, Ralph, Thorne, Rick F., Kiejda, Kelly A., Zhang, Xu Dong, Hersey, Peter

Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress

- Jiang, Chen Chen, Lucas, Keryn, Avery-Kiejda, Kelly A., Wade, Margaret, deBock, Charles E., Thorne, Rick F., Allen, John, Hersey, Peter, Zhang, Xu Dong

An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development

- Cullinane, Carleen, Dorow, Donna S., Kansara, Maya, Conus, Nelly, Binns, David, Hicks, Rodney J., Ashman, Leonie Kay, McArthur, Grant A., Thomas, David M.

An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development

- Cullinane, C., Dorow, D. S., Kansara, M., Conus, N., Binns, D., Hicks, R. J., Ashman, Leonie K., McArthur, G. A., Thomas, D. M.

CDKN2A common variants and their association with melanoma risk: A population-based study

- Debniak, T., Scott, Rodney J., Huzarski, T., Byrski, T., Rozmiarek, A., Debniak, B., Zaluga, E., Maleszka, R., Kladny, J., Gorski, B., Cybulski, C., Gronwald, J., Kurzawski, G., Lubinski, J.

The antifolate activity of tea catechins (letter)

- Lucock, Mark D., Roach, Paul D.

The NOD2 3020insC mutation and the risk of colorectal cancer

- Kurzawski, Grzegorz, Suchy, Janina, Domagala, Wenancjusz, Scott, Rodney J., Lubinski, Jan, Kladny, Jozef, Grabowska, Ewa, Mierzejewski, Marek, Jakubowska, Anna, Debniak, Tadeusz, Cybulski, Cezary, Kowalska, Elsbieta, Szych, Zbigniew

A CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells

- Bates, Richard C., Edwards, Nathaniel S., Burns, Gordon F., Fisher, David E.